Publications | Research impact

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.

ELLIOTT, AM; Luzze, H; Quigley, MA; Nakiyingi, JS; Kyaligonza, S; Namujju, PB; Ducar, C; Ellner, JJ; WHITWORTH, JA G; Mugerwa, R; Johnson, JL; Okwera, A;

2004

The Journal of infectious diseases, (2004).190 5 10.1086/422257.

HIV and AIDS among fisherfolk: a threat to 'responsible fisheries'?.

Allison, EH; SEELEY, JA;

2004

Fish and fisheries (Oxford, England), (2004).5 3 10.1111/j.1467-2679.2004.00153.x.

Another group at high risk for HIV.

Allison, EH; SEELEY, JA;

2004

Science (New York, NY), (2004).305 5687 10.1126/science.305.5687.1104b.

Full-length HIV-1 Tat protein necessary for a vaccine.

Opi, S; Péloponèse, J-M; Esquieu, D; Watkins, J; Campbell, G; De Mareuil, J; Jeang, KT; Yirrell, DL; KALEEBU, P; Loret, EP;

2004

Vaccine, (2004).22 23-24 10.1016/j.vaccine.2004.01.057.

Gender and HIV/AIDS impact mitigation in sub-Saharan Africa--recognising the constraints.

SEELEY, J; Grellier, R; BARNETT, T;

2004

SAHARA J, (2004).1 2 10.1080/17290376.2004.9724831.

Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.

Joseph, S; Jones, FM; Laidlaw, ME; Mohamed, G; MAWA, PA; Namujju, PB; Kizza, M; Watera, C; WHITWORTH, JA G; Dunne, DW; ELLIOTT, AM;

2004

The Journal of infectious diseases, (2004).190 3 10.1086/422396.

Subgroup report: stomach cancer.

NEWTON, R; Rice, J; Buffler, P;

2004

IARC scientific publications (2004).

Low socioeconomic status and risk for infection with human herpesvirus 8 among HIV-1 negative, South African black cancer patients.

Wojcicki, JM; NEWTON, R; Urban, M; Stein, L; Hale, M; Patel, M; Ruff, P; Sur, R; Bourboulia, D; Sitas, F;

2004

Epidemiology and infection, (2004).132 6 10.1017/s0950268804002845.

Support for the RV144 HIV vaccine trial.

Belshe, R; Franchini, G; Girard, MP; Gotch, F; KALEEBU, P; Marthas, ML; McChesney, MB; McCullough, R; Mhalu, F; Salmon-Ceron, D; Sekaly, R-P; Van Rompay, K; Verrier, B; Wahren, B; Weissenbacher, M;

2004

Science (New York, N.Y.), (2004).305 5681 10.1126/science.305.5681.177b.

Support for the RV144 HIV vaccine trial [1] (multiple letters).

Belshe, R; Franchini, G; Girard, MP; Gotch, F; KALEEBU, P; Marthas, ML; McChesney, MB; McCullough, R; Mhalu, F; Salmon-Ceron, D; Sekaly, RP; Van Rompay, K; Verrier, B; Wahren, B; Weissenbacher, M; Baehr, M; Cappiello, D; Collins, C; Gold, D; Kaleebu, P; Menezes, A; Powell, M; Reinhard, R; Santiago, L; Snow, B; ... Gallo, RC.

2004

Science, (2004).305 5681